Genomics of squamous cell lung cancer

Related Experiment Video

Updated: May 10, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Melissa Rooney1, Siddhartha Devarakonda, Ramaswamy Govindan

  • 1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63021, USA.

The Oncologist
|June 4, 2013
PubMed

Insights

Squamous cell lung cancer (SQCC) lacks targeted therapies. Genomic analysis from The Cancer Genome Atlas (TCGA) reveals molecular aberrations, offering potential therapeutic targets for this non-small cell lung cancer subtype.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Squamous cell carcinoma (SQCC) represents approximately 30% of non-small cell lung cancer (NSCLC) cases.
  • Unlike lung adenocarcinoma, SQCC currently lacks approved targeted therapies, highlighting a significant unmet clinical need.
  • Recent comprehensive genomic analyses by The Cancer Genome Atlas (TCGA) provide new insights into SQCC molecular landscape.

Purpose of the Study:

  • To review key molecular aberrations identified in lung SQCC by TCGA and other research groups.
  • To discuss the potential therapeutic implications of these identified molecular aberrations.
  • To emphasize the need for targeted preclinical and clinical studies to advance SQCC treatment.

Main Methods:

  • Review of comprehensive genomic analyses data from The Cancer Genome Atlas (TCGA) for 178 SQCC patients.
  • Integration of findings from other relevant molecular investigations in lung SQCC.
  • Analysis of potential therapeutic strategies based on identified genomic alterations.

Main Results:

  • TCGA and other studies have identified several key molecular aberrations specific to lung SQCC.
  • These aberrations represent potential targets for novel therapeutic interventions.
  • Understanding the genomic drivers is crucial for developing effective treatments.

Conclusions:

  • Genomic insights from TCGA are pivotal for understanding lung SQCC.
  • Targeting identified molecular aberrations holds promise for future SQCC therapies.
  • Further preclinical and clinical research is essential to translate these findings into improved patient outcomes.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...